PolyPeptide Shareholders Approve Board Proposals at Extraordinary Meeting

PolyPeptide Group AG announced that its shareholders approved all Board proposals during the extraordinary general meeting on 26 October 2026. Key decisions included the election of John Chongbo Rim as chair of the Board, along with Seungho Ryu, Cheol Woo Ryu, Mihyun Yang, and Joonkyung Seong as Board members. Additionally, Seungho Ryu and Cheol Woo Ryu were named to the Remuneration and Nomination Committee.

The elections are contingent upon the settlement of Samsung Peptide AG's public tender offer for all registered shares of PolyPeptide. Shareholders also agreed to amend the articles of association, removing transfer restrictions and voting limitations, subject to specific conditions outlined in Samsung Peptide AG's offer prospectus.